Form 8-K - Current report:
SEC Accession No. 0001047469-19-005409
Filing Date
2019-09-24
Accepted
2019-09-24 14:04:07
Documents
7
Period of Report
2019-09-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a2239754z8-k.htm 8-K 57963
2 EX-2.1 a2239754zex-2_1.htm EX-2.1 673764
3 EX-10.1 a2239754zex-10_1.htm EX-10.1 94295
4 EX-10.2 a2239754zex-10_2.htm EX-10.2 96295
5 EX-10.3 a2239754zex-10_3.htm EX-10.3 28245
6 EX-10.4 a2239754zex-10_4.htm EX-10.4 374469
7 EX-10.5 a2239754zex-10_5.htm EX-10.5 160279
  Complete submission text file 0001047469-19-005409.txt   1486630
Mailing Address 200 WEST STREET WALTHAM MA 02451
Business Address 200 WEST STREET WALTHAM MA 02451 781-890-0102
PROTEON THERAPEUTICS INC (Filer) CIK: 0001359931 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36694 | Film No.: 191110409
SIC: 2836 Biological Products, (No Diagnostic Substances)